Log In
BCIQ
Print this Print this
 

Glionix

  Manage Alerts
Collapse Summary General Information
Company Activate Immunotherapy
DescriptionGlioma cell lines carrying antisense oligonucleotide against transforming growth factor (TGF) beta 1 and transforming growth factor (TGF) beta 2
Molecular Target Not applicable
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Cellular vaccine
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat glioma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today